TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling. (Q54321573)

27 May 2018

title

TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling. (English)

1 reference

27 May 2018

0 references

1 reference

Steen Dissing

11

0 references

author name string

Hong Ji

1

1 reference

27 May 2018

Renhai Cao

2

1 reference

27 May 2018

Yunlong Yang

3

1 reference

27 May 2018

Yin Zhang

4

1 reference

27 May 2018

Hideki Iwamoto

5

1 reference

27 May 2018

Sharon Lim

6

1 reference

27 May 2018

Masaki Nakamura

7

1 reference

27 May 2018

Patrik Andersson

8

1 reference

27 May 2018

Jian Wang

9

1 reference

27 May 2018

Yuping Sun

10

1 reference

27 May 2018

Xia He

12

1 reference

27 May 2018

Xiaojuan Yang

13

1 reference

27 May 2018

Yihai Cao

14

1 reference

27 May 2018

language of work or name

English

0 references

publication date

17 September 2014

1 reference

27 May 2018

published in

Nature Communications

1 reference

27 May 2018

volume

5

1 reference

27 May 2018

page(s)

4944

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1038/ncomms5944

exact match

0 references

cites work

The TRAIL apoptotic pathway in cancer onset, progression and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

From bench to clinic with apoptosis-based therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor necrosis factor: an apoptosis JuNKie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Clinical targeting of the TNF and TNFR superfamilies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

TNF receptor 2 pathway: drug target for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Lymphangiogenesis in development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Lymphangiogenesis: Molecular mechanisms and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

An important role of lymphatic vessel activation in limiting acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Lymph node metastasis in stages I and II ovarian cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Functional analyses of TNFR2 in physiological and pathological retina angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Macrophage biology in development, homeostasis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Profound but Dysfunctional Lymphangiogenesis via Vascular Endothelial Growth Factor Ligands from CD11b+ Macrophages in Advanced Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

Tumour necrosis factor and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

7 January 2021

Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by the specific inhibitor L1-10

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

7 January 2021

Mouse corneal lymphangiogenesis model

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

7 January 2021

Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

7 January 2021

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5944

7 January 2021

Identifiers

DOI

10.1038/NCOMMS5944

1 reference

27 May 2018

Dimensions Publication ID

ADS bibcode

2014NatCo...5.4944J

0 references

0 references

1 reference

27 May 2018